| Pharmacogenomics of COVID-19 therapies T Takahashi, JA Luzum, MR Nicol, PA Jacobson NPJ genomic medicine 5 (1), 35, 2020 | 86 | 2020 |
| Acute chest syndrome among children hospitalized with vaso‐occlusive crisis: a nationwide study in the United States T Takahashi, Y Okubo, A Handa Pediatric Blood & Cancer 65 (3), e26885, 2018 | 28 | 2018 |
| ‘Down-triage’for children with abnormal vital signs: evaluation of a new triage practice at a paediatric emergency department in Japan T Takahashi, N Inoue, N Shimizu, T Terakawa, RD Goldman Emergency Medicine Journal 33 (8), 533-537, 2016 | 25 | 2016 |
| Development of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence: a retrospective cohort study T Takahashi, H Sakakibara, Y Morikawa, M Miura Pediatric Rheumatology 13, 1-8, 2015 | 25 | 2015 |
| Safety and efficacy of gamma‐secretase inhibitor nirogacestat (PF‐03084014) in desmoid tumor: Report of four pediatric/young adult cases T Takahashi, JR Prensner, CD Robson, KA Janeway, BJ Weigel Pediatric blood & cancer 67 (10), e28636, 2020 | 19 | 2020 |
| Childhood leptospirosis in an industrialized country: Population-based study in Okinawa, Japan K Tomari, T Toyokawa, T Takahashi, T Kakita, S Okano, H Kyan, ... PLoS neglected tropical diseases 12 (3), e0006294, 2018 | 17 | 2018 |
| CYP2C19 phenotype and body weight-guided voriconazole initial dose in infants and children after hematopoietic cell transplantation T Takahashi, MA Mohamud, AR Smith, PA Jacobson, MM Jaber, ... Antimicrobial agents and chemotherapy 65 (9), 10.1128/aac. 00623-21, 2021 | 14 | 2021 |
| Factors associated with mechanical ventilation use in children with sickle cell disease and acute chest syndrome T Takahashi, Y Okubo, MA Pereda, A Handa, S Miller Pediatric Critical Care Medicine 19 (9), 801-809, 2018 | 14 | 2018 |
| In‐hospital mortality of hematopoietic stem cell transplantation among children with nonmalignancies: a nationwide study in the United States from 2000 to 2012 T Takahashi, MA Pereda, N Bala, S Nagarajan Pediatric blood & cancer 66 (6), e27626, 2019 | 10 | 2019 |
| Late-onset acute and chronic graft-versus-host disease in children: clinical features and response to therapy T Takahashi, M Arora, G Okoev, TE DeFor, DJ Weisdorf, ML MacMillan Transplantation and Cellular Therapy 27 (8), 667. e1-667. e5, 2021 | 8 | 2021 |
| Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant G Okoev, DJ Weisdorf, JE Wagner, BR Blazar, ML MacMillan, T DeFor, ... Bone marrow transplantation 56 (6), 1373-1380, 2021 | 7 | 2021 |
| Predictive Value of C‐Reactive Protein and Albumin for Temporal Within‐Individual Pharmacokinetic Variability of Voriconazole in Pediatric Patients Undergoing Hematopoietic … T Takahashi, MM Jaber, AR Smith, PA Jacobson, J Fisher, MN Kirstein The Journal of Clinical Pharmacology 62 (7), 855-862, 2022 | 6 | 2022 |
| Impact of obesity on voriconazole pharmacokinetics among pediatric hematopoietic cell transplant recipients T Takahashi, AR Smith, PA Jacobson, J Fisher, NT Rubin, MN Kirstein Antimicrobial agents and chemotherapy 64 (12), 10.1128/aac. 00653-20, 2020 | 6 | 2020 |
| Higher fludarabine and cyclophosphamide exposures lead to worse outcomes in reduced-intensity conditioning hematopoietic cell transplantation for adult hematologic malignancy T Takahashi, A Scheibner, Q Cao, R Pearson, K Sanghavi, DJ Weisdorf, ... Transplantation and cellular therapy 27 (9), 773. e1-773. e8, 2021 | 5 | 2021 |
| Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events T Takahashi, M Al-Kofahi, M Jaber, B Bratrude, K Betz, Y Suessmuth, ... Blood 142 (8), 700-710, 2023 | 4 | 2023 |
| Busulfan dose recommendation in inherited metabolic disorders: population pharmacokinetic analysis T Takahashi, SM Illamola, CA Jennissen, SE Long, TC Lund, PJ Orchard, ... Transplantation and Cellular Therapy 28 (2), 104. e1-104. e7, 2022 | 4 | 2022 |
| CYP51A1 polymorphism and voriconazole-associated hepatotoxicity in children undergoing hematopoietic cell transplant T Takahashi, AR Smith, PA Jacobson, AF Alharbi, J Fisher, NT Rubin, ... International Journal of Clinical Pharmacology and Therapeutics 59 (6), 442, 2021 | 4 | 2021 |
| Effects of cyclophosphamide related genetic variants on clinical outcomes of adult hematopoietic cell transplant patients T Takahashi, R Pearson, Q Cao, A Scheibner, K Sanghavi, D Weisdorf, ... Cancer chemotherapy and pharmacology 89 (4), 543-549, 2022 | 3 | 2022 |
| T-cell depleted haploidentical hematopoietic cell transplantation for pediatric malignancy T Takahashi, SE Prockop Frontiers in Pediatrics 10, 987220, 2022 | 2 | 2022 |
| Population pharmacokinetics of total rabbit anti-thymocyte globulin in non-obese adult patients undergoing hematopoietic cell transplantation for hematologic malignancy T Takahashi, M Teramoto, K Matsumoto, MM Jaber, H Tamaki, K Ikegame, ... Clinical Pharmacokinetics 62 (8), 1081-1091, 2023 | 1 | 2023 |
